|
Volumn 221, Issue 1-2, 2001, Pages 143-152
|
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
|
Author keywords
Biodistribution; Effect of dose; Pharmacokinetics; Poly(Lactide co glycolide); Poly(Lactide co glycolide) monomethoxy (polyethyleneglycol)
|
Indexed keywords
ANILINE DERIVATIVE;
CHOLESTERYLANILINE;
ETHYLENE GLYCOL DERIVATIVE;
IODINE 125;
NANOPARTICLE;
POLY(LACTIDE GLYCOLIDE) MONOMETHOXYPOLY(ETHYLENEGLYCOL);
POLYGLACTIN;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
AREA UNDER THE CURVE;
ARTICLE;
CONTROLLED STUDY;
DIFFUSION;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG FORMULATION;
DRUG STABILITY;
DRUG TARGETING;
FEMALE;
MONONUCLEAR PHAGOCYTE;
MOUSE;
NONHUMAN;
PLASMA CLEARANCE;
POLYMERIZATION;
PRECIPITATION;
PRIORITY JOURNAL;
RADIOACTIVITY;
TISSUE DISTRIBUTION;
ANIMALS;
AREA UNDER CURVE;
BIOCOMPATIBLE MATERIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HALF-LIFE;
INJECTIONS, INTRAVENOUS;
LACTIC ACID;
METABOLIC CLEARANCE RATE;
MICE;
PARTICLE SIZE;
POLYETHYLENE GLYCOLS;
POLYGLACTIN 910;
POLYGLYCOLIC ACID;
POLYMERS;
TISSUE DISTRIBUTION;
|
EID: 0035912958
PISSN: 03785173
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-5173(01)00676-7 Document Type: Article |
Times cited : (215)
|
References (16)
|